Billiontoone, Inc. (NASDAQ:BLLN) Receives Average Rating of “Moderate Buy” from Brokerages

Shares of Billiontoone, Inc. (NASDAQ:BLLN) have been given a consensus rating of “Moderate Buy” by the ten analysts that are presently covering the firm, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, three have given a hold recommendation and six have given a buy recommendation to the company. The average twelve-month price target among brokerages that have updated their coverage on the stock in the last year is $125.2857.

A number of equities research analysts recently weighed in on BLLN shares. Wells Fargo & Company decreased their target price on Billiontoone from $110.00 to $90.00 and set an “equal weight” rating on the stock in a research report on Thursday, March 5th. Weiss Ratings raised Billiontoone from a “sell (d)” rating to a “sell (d+)” rating in a research report on Friday, May 15th. Wall Street Zen raised Billiontoone from a “hold” rating to a “buy” rating in a research report on Saturday, March 7th. BTIG Research decreased their target price on Billiontoone from $140.00 to $130.00 and set a “buy” rating on the stock in a research report on Thursday, May 7th. Finally, JPMorgan Chase & Co. lifted their target price on Billiontoone from $120.00 to $125.00 and gave the stock an “overweight” rating in a research report on Thursday, May 7th.

Billiontoone Price Performance

BLLN stock opened at $98.99 on Monday. Billiontoone has a twelve month low of $61.96 and a twelve month high of $138.70. The firm has a market capitalization of $4.55 billion and a P/E ratio of 179.98. The business’s 50-day moving average price is $83.46. The company has a current ratio of 10.92, a quick ratio of 10.58 and a debt-to-equity ratio of 0.18.

Billiontoone (NASDAQ:BLLN) last released its earnings results on Wednesday, May 6th. The company reported $0.34 earnings per share for the quarter, topping analysts’ consensus estimates of $0.01 by $0.33. The firm had revenue of $108.39 million for the quarter, compared to analyst estimates of $95.81 million. During the same period last year, the business earned ($0.39) earnings per share. The firm’s quarterly revenue was up 83.8% compared to the same quarter last year. On average, equities research analysts anticipate that Billiontoone will post 0.93 EPS for the current year.

Institutional Investors Weigh In On Billiontoone

A number of institutional investors have recently added to or reduced their stakes in the stock. Rossby Financial LCC acquired a new stake in Billiontoone during the fourth quarter valued at approximately $25,000. Wells Fargo & Company MN acquired a new stake in Billiontoone during the fourth quarter valued at approximately $76,000. Smartleaf Asset Management LLC acquired a new stake in Billiontoone during the fourth quarter valued at approximately $80,000. Nano Cap New Millennium Growth Fund L P acquired a new stake in Billiontoone during the fourth quarter valued at approximately $82,000. Finally, Renaissance Capital LLC acquired a new stake in Billiontoone during the fourth quarter valued at approximately $201,000.

About Billiontoone

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.